AMENDMENT NO. 1 TO NON-QUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE BIORESTORATIVE THERAPIES, INC.Non-Qualified Stock Option Award Agreement • March 30th, 2022 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 30th, 2022 Company IndustryThis Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December 10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Lance Alstodt (the “Participant”).
AMENDMENT NO. 1 TO NON-QUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE BIORESTORATIVE THERAPIES, INC.Non-Qualified Stock Option Award Agreement • March 30th, 2022 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 30th, 2022 Company IndustryThis Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December 10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Francisco Silva (the “Participant”).
AMENDMENT NO. 1 TO NON-QUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE BIORESTORATIVE THERAPIES, INC.Non-Qualified Stock Option Award Agreement • March 30th, 2022 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 30th, 2022 Company IndustryThis Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December 10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Nickolay Kukekov (the “Participant”).
AMENDMENT NO. 1 TO NON-QUALIFIED STOCK OPTION AWARD AGREEMENT UNDER THE BIORESTORATIVE THERAPIES, INC.Non-Qualified Stock Option Award Agreement • March 30th, 2022 • BioRestorative Therapies, Inc. • Services-misc health & allied services, nec
Contract Type FiledMarch 30th, 2022 Company IndustryThis Amendment No. 1 to Non-Qualified Stock Option Award Agreement (this “Amendment”) is made and entered into as of December 10, 2021 by and between BioRestorative Therapies, Inc., a Delaware corporation (the “Company”), and Patrick Williams (the “Participant”).